📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. (2024)

First Author: Cardoso P

Attributed to: MICA: MRC APBI STratification and Extreme Response Mechanism IN Diabetes - MASTERMIND funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s00125-024-06099-3

PubMed Identifier: 38388753

Publication URI: http://europepmc.org/abstract/MED/38388753

Type: Journal Article/Review

Volume: 67

Parent Publication: Diabetologia

Issue: 5

ISSN: 0012-186X